• Cryptomonnaies
  • Marchés de Prédiction
  • Actualités
  • Trading Agentique
  • Articles
  • Ligues

Rechercher des Cryptomonnaies

Cryptomonnaies en tendance

CoinRithm

Entreprise

Entité légale
Bees-x Limited
Numéro de société
13308136
Constituée en
England and Wales
Siège social
Monmouth House, High Street, Watford, England, WD17 1LN

CoinRithm est un service d'information et de recherche exploité par Bees-x Limited. Il n'est pas autorisé par la Financial Conduct Authority (FCA) à exercer des activités réglementées, et rien sur ce site ne constitue un conseil financier.

Explorer

CryptomonnaiesMarchés de PrédictionActualitésArticlesAgent ArenaLigues

Fonctionnalités

Tableau de bordÉchange FictifTrading AgentiquePortefeuilleListe de suiviParamètres

Entreprise

À Propos de NousMethodologieConditions d'utilisationPolitique de ConfidentialitéPolitique en Matière de CookiesAvertissement

Support

Contactez le SupportFAQKit développeurDocs MCP

Réseaux

X (Twitter)FacebookLinkedInTelegramInstagramTikTokYouTube
© 2026 CoinRithm. Tous droits réservés.
Disponible sur Google PlayTélécharger sur l'App Store
  • Accueil
  • MarchésMarchés de Prédiction
  • Actualités
  • Tableau de bord
  1. Marchés de Prédiction
  2. Health & Medicine
  3. When will Intellia Therapeutics submit a BLA for Lonvo-z?
When will Intellia Therapeutics submit a BLA for Lonvo-z?

When will Intellia Therapeutics submit a BLA for Lonvo-z?

Health & MedicineOne-OffScience2mo
KalshiKalshiVérifier la disponibilitéKYC requis2% de frais
Probabilité implicite actuelle
before September
before September 45%
En tête parmi 6 options
Qualite du marche

24 / 100

Faible qualité
Volume 24h

0 €

Liquidité

20,7 €

Faible liquidité
Achat / Vente

35.0% / 45.0%

Spread

28.6%

Spread large
Données du marché

Mis à jour il y a 4 minutes

24 mars 26, 14:001 sept. 26, 14:00

Tendances

Résultat24hProbabilité

Résultat choisi

before September45%

Règles

If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Sep 1, 2026, then the market resolves to Yes.

Kalshi
  • If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Oct 1, 2026, then the market resolves to Yes.
  • If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Nov 1, 2026, then the market resolves to Yes.
  • If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Dec 1, 2026, then the market resolves to Yes.
  • If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Jan 1, 2027, then the market resolves to Yes.
  • If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Apr 1, 2027, then the market resolves to Yes.

Marchés Associés

When will Beam Therapeutics submit a BLA for Risto-cel?

When will Beam Therapeutics submit a BLA for Risto-cel?

4,6 €
before April 2027: 72%KalshiKALSHI
When will Compass Pathways submit a NDA for COMP360 psilocybin?

When will Compass Pathways submit a NDA for COMP360 psilocybin?

0,3 €
before September: 31%KalshiKALSHI
Will there be a year without polio before 2030?

Will there be a year without polio before 2030?

0 €
Oui: 10%KalshiKALSHI
Which countries will have an Ebola case in 2026?

Which countries will have an Ebola case in 2026?

138,2 €
Uganda: 100%PolymarketPOLYMARKET
Hantavirus pandemic in 2026?

Hantavirus pandemic in 2026?

147,6 k €
Oui: 5%PolymarketPOLYMARKET
New pandemic in 2026?

New pandemic in 2026?

16,6 k €
Oui: 10%PolymarketPOLYMARKET

Actifs dans ces sujets

BitcoinBTC$62,835.25+1.92%EthereumETH$1,657.81+1.25%SolanaSOL$65.23+1.59%DogecoinDOGE$0.0851+1.38%XRPXRP$1.12+0.44%BNBBNB$601.79+2.49%

Actualités Associées

Anthropic’s Claude Tackles Chemistry with NMR Structure AnalysisBlockchain.NewsChainalysis reveals $100 million peptide market built on cryptoCrypto NewsGray peptide vendors embrace stablecoins as safety fears deepenCrypto NewsOpenAI Expands GPT-Rosalind Access with Rosalind BiodefenseBlockchain.NewsQuantus’ Q-Day Brings Together Leading Cryptographers, Blockchain Builders, Investors, and Researchers to Prepare for the Post-Quantum FutureBlockchain ReporterOpenAI Expands GPT-Rosalind Capabilities for Life SciencesBlockchain.News

Règles

If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Sep 1, 2026, then the market resolves to Yes.

Kalshi
  • If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Oct 1, 2026, then the market resolves to Yes.
  • If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Nov 1, 2026, then the market resolves to Yes.
  • If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Dec 1, 2026, then the market resolves to Yes.
  • If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Jan 1, 2027, then the market resolves to Yes.
  • If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Apr 1, 2027, then the market resolves to Yes.